| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $6.3M | +0.0% |
| R&D Expense | $70.0M | +2.1% |
| SG&A Expense | $24.1M | -16.1% |
| Operating Income | -$94.1M | +29.1% |
| Pre-tax Income | -$93.1M | +29.7% |
| Income Tax | $0 | +100.0% |
| Net Income | -$93.1M | +28.3% |
| EPS (Basic) | -$1.92 | +36.0% |
| EPS (Diluted) | -$1.92 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $52.4M | +14.9% |
| Accounts Receivable | $944K | +181.0% |
| Current Assets | $97.0M | -37.1% |
| Total Assets | $101.8M | -46.7% |
| Current Liabilities | $16.3M | +1.4% |
| Total Liabilities | $19.1M | -13.6% |
| Stockholders' Equity | $82.7M | -51.1% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$84.5M | +9.6% |
| Capital Expenditures | $102K | -96.7% |
| Investing Cash Flow | $90.6M | +241.8% |
| Financing Cash Flow | $614K | -98.8% |
| Free Cash Flow | -$84.6M | +12.4% |
| +36.0% |